List of nationally authorised medicinal products



Similar documents
ERASMUS+ MASTER LOANS

1. Perception of the Bancruptcy System Perception of In-court Reorganisation... 4

Labour Force Survey 2014 Almost 10 million part-time workers in the EU would have preferred to work more Two-thirds were women

International Hints and Tips

ERASMUS+ MASTER LOANS

Energy prices in the EU Household electricity prices in the EU rose by 2.9% in 2014 Gas prices up by 2.0% in the EU

41 T Korea, Rep T Netherlands T Japan E Bulgaria T Argentina T Czech Republic T Greece 50.

COMMUNICATION FROM THE COMMISSION

187/ December EU28, euro area and United States GDP growth rates % change over the previous quarter

99/ June EU28, euro area and United States GDP growth rates % change over the previous quarter

ENTERING THE EU BORDERS & VISAS THE SCHENGEN AREA OF FREE MOVEMENT. EU Schengen States. Non-Schengen EU States. Non-EU Schengen States.

Size and Development of the Shadow Economy of 31 European and 5 other OECD Countries from 2003 to 2015: Different Developments

NEW PASSENGER CAR REGISTRATIONS BY ALTERNATIVE FUEL TYPE IN THE EUROPEAN UNION 1 Quarter

ERMInE Database. Presentation by Nils Flatabø SINTEF Energy Research. ERMInE Workshop 2 - Northern Europe Oslo, 1. November 2006

Planned Healthcare in Europe for Lothian residents

168/ November At risk of poverty or social exclusion 2 rate in the EU28, (% of total population)

Implementing the cooperation mechanisms of the RES directive current status and open questions

SURVEY ON THE TRAINING OF GENERAL CARE NURSES IN THE EUROPEAN UNION. The current minimum training requirements for general care nurses

Computing our Future Computer programming and coding in schools in Europe. Anja Balanskat, Senior Manager European Schoolnet

Alcohol Consumption in Ireland A Report for the Health Service Executive

Keeping European Consumers safe Rapid Alert System for dangerous non-food products 2014

Family benefits Information about health insurance country. Udbetaling Danmark Kongens Vænge Hillerød. A. Personal data

European Research Council

Waste. Copenhagen, 3 rd September Almut Reichel Project Manager Sustainable consumption and production & waste, European Environment Agency

Cash machine withdrawal in the EU (+Norway and Iceland)

ERASMUS+ MASTER LOANS

Application Form: Receptionist / PA to the Senior Leadership Team

INTERNATIONAL TRACKED POSTAGE SERVICE

RULES FOR THE REIMBURSEMENT OF TRAVEL AND SUBSISTENCE EXPENSES FOR EXCHANGE OF OFFICIALS

Product name Strength Pharmaceutical form. 100/6 micrograms per actuation. Formodual 100/6 Mikrogramm/Sprüh stoß, Druckgasinhalation, Lösung

SEPA. Changes in the Payment System Implementation of the European SEPA Regulations for Kuna and Euro Payments

EUF STATISTICS. 31 December 2013

Employee eligibility to work in the UK

Report from the CMDh meeting held on September !!! 3 months to go until the mandatory use of the electronic application form!!!

The Guardianship Service

193/ December Hourly labour costs in the EU28 Member States, 2012 (in )

Health care in Scotland for UK passport holders living abroad

Equity Release Schemes in the European Union

Dublin, March EPSO Network of Experts in the field of Personnel Selection 14th March 2013

OVERVIEW OF PURCHASE AND TAX INCENTIVES FOR ELECTRIC VEHICLES IN THE EU

Annex I. Article 31 of Directive 2001/83/EC. Procedure number: EMEA/H/A-31/1448

Erasmus+ International Cooperation

CO2 BASED MOTOR VEHICLE TAXES IN THE EU IN 2015

Funding and network opportunities for cluster internationalization

13 th Economic Trends Survey of the Architects Council of Europe

Credit transfer to Customer account with AS "Meridian Trade Bank" EUR, USD free of charge * Other countries currency information in the Bank

European Research Council

The European regulatory system for medicines and the European Medicines Agency

Wind Power in Germany in 2014

EUROPE 2020 TARGETS: RESEARCH AND DEVELOPMENT

First estimate for 2014 Euro area international trade in goods surplus bn 24.2 bn surplus for EU28

How To Study The Small Ruminant Population In The European Land Animals

W I R E T R A N S F E R S E R V I C E S

TPI: Traffic Psychology International on a common European curriculum for postgraduate education in traffic psychology

Our patent and trade mark attorneys are here to help you protect and profit from your ideas, making sure they re working every bit as hard as you do.

in Scotland for holidaymakers from overseas

TOYOTA I_SITE More than fleet management

I have asked for asylum in the EU which country will handle my claim?

Chase Online SM Wire Transfer Help Guide page 1 of 16. How to Send Wire Transfers on Chase Online SM

INNOBAROMETER THE INNOVATION TRENDS AT EU ENTERPRISES

About us. As our customer you will be able to take advantage of the following benefits: One Provider. Flexible Billing. Our Portal.

Need to send money abroad securely?

GfK PURCHASING POWER INTERNATIONAL

FUSIONS Food waste data set for EU-28. New Estimates and Environmental Impact

How To Understand The Transparent Directive 2

Reporting practices for domestic and total debt securities

Study on comparison tools and third-party verification schemes

C h a r t 1 - KPNQwest Group

General information about the bank

CCBE LAWYERS STATISTICS 2015 Total n of women lawyer members of the Bar Austria 31/12/

FEDERATION EUROPEENNE DE LA MANUTENTION Product Group. industrial trucks. A brief guide for identification of noncompliant. - Exhaust Emission -

Comparison of annuity markets (OECD National Annuity Markets: Features and Implications, Rusconi 2008) Mercer

Adobe Public Relations (PR) Guidelines

SUPPLEMENTARY PROTECTION CERTIFICATES FOR MEDICINAL PRODUCTS

SMEs access to finance survey 2014

Crystal Clear Contract Services Limited Application Form CIS/Sole Trader

Students: undergraduate and graduate students who are currently enrolled in universities

Analysis on European landscape & Match making tool for Photonics Industry & Research

CENTRAL BANK OF CYPRUS

International ACH: Payment Gateway to Europe

THE ORGANISATION AND FINANCING OF HEALTH CARE SYSTEM IN LATVIA

This document is a preview generated by EVS

PLANT PROTECTION AND BIOCIDAL PRODUCT AUTHORISATION IN EUROPE

EUROPEANS SATISFACTION WITH RAIL SERVICES

INNOVATION IN THE PUBLIC SECTOR: ITS PERCEPTION IN AND IMPACT ON BUSINESS

Business Cooperation Database Profile Extraction

THE ROLE OF PUBLIC SUPPORT IN THE COMMERCIALISATION OF INNOVATIONS

- Assessment of the application by Member States of European Union VAT provisions with particular relevance to the Mini One Stop Shop (MOSS) -

Statistical Data on Women Entrepreneurs in Europe

How To Calculate Tax Burden In European Union

EUROPEAN YOUTH: PARTICIPATION IN DEMOCRATIC LIFE

BEST PRACTICES/ TRENDS/ TO-DOS

Transcription:

9 July 2015 EMA/483660/2015 Procedure Management and Committees Support Active substance: diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated), haemophilus type b conjugate vaccine Procedure no.: PSUSA/00001124/201411 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact An agency of the European Union European Medicines Agency, 2015. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation country) MRP/DCP Authorisation number National Authorisation Number MAH of product in the member state Member State where product is authorised Ditekipol/Act-Hib 32847 Statens Serum Institut Denmark Infanrix-Ipv+hib DE/H/0145/002 2-00370 Glaxosmithkline Pharma Gmbh. Austria Infanrix-IPV+hib DE/H/0145/002 HR-H-255493749 Glaxosmithkline D.O.O. Croatia Infanrix-Ipv+hib DE/H/0145/002 59/101/05-C Glaxosmithkline Biologicals S.A. Czech Republic Infanrix-Ipv+hib 329900 Glaxosmithkline Biologicals S.A. Estonia Infanrix-Ipv+hib DE/H/0145/002 76A/97 Glaxosmithkline Gmbh & Co. Kg Germany Infanrix-Ipv+hib DE/H/0145/002 PA 1077/029/002 Glaxosmithkline (Ireland) Limited Ireland Infanrix-Ipv+hib 00-1011 Glaxosmithkline Biologicals S.A. Latvia Infanrix-Ipv+hib LT/1/2000/2129/001 Glaxosmithkline Lietuva Uab Lithuania Infanrix-Ipv+hib MA172/00901 Smithkline Beecham Plc Malta Infanrix-Ipv+hib RVG34567 Glaxosmithkline B.V. Netherlands Infanrix-Ipv+hib 8916 Glaxosmithkline Biologicals S.A. Poland Infanrix-Ipv+hib DE/H/0145/002 2856383 Infanrix-Ipv+hib DE/H/0145/002 2856482 Infanrix-Ipv+hib DE/H/0145/002 2856581 Infanrix-Ipv+hib DE/H/0145/002 2857688 Infanrix-Ipv+hib DE/H/0145/002 2857787 Infanrix-Ipv+hib DE/H/0145/002 2857886 Infanrix-Ipv+hib DE/H/0145/002 2857985 Infanrix-Ipv+hib DE/H/0145/002 2858082 Infanrix-Ipv+hib DE/H/0145/002 2858181 Infanrix-Ipv+hib DE/H/0145/002 4059283 Infanrix-Ipv+hib DE/H/0145/002 4059382 Infanrix-Ipv+hib DE/H/0145/002 4059481 Infanrix-Ipv+hib DE/H/0145/002 4059580 EMA/483660/2015 Page 2/5

Infanrix-Ipv+hib DE/H/0145/002 4059689 Infanrix-Ipv+hib DE/H/0145/002 4059788 Infanrix-Ipv+hib DE/H/0145/002 4059887 Infanrix-Ipv+hib DE/H/0145/002 4059986 Infanrix-Ipv+hib DE/H/0145/002 4060083 Infanrix-Ipv+hib DE/H/0145/002 4060182 Infanrix-Ipv+hib DE/H/0145/002 4068680 Infanrix-Ipv+hib DE/H/0145/002 4068789 Infanrix-Ipv+hib 5880/2013/01 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/02 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/03 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/04 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/05 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/06 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/07 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/08 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/09 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/10 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/11 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/12 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/13 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/14 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/15 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/16 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/17 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/18 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/19 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/20 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib 5880/2013/21 Glaxosmithkline Biologicals S.A. Romania Infanrix-Ipv+hib DE/H/0145/002 59/0416/08-S Glaxosmithkline Biologicals S.A. Slovakia Infanrix-Ipv+hib 5363-I-1250/13 Gsk D.O.O. Slovenia EMA/483660/2015 Page 3/5

Infanrix-Ipv+hib 62.827 Glaxosmithkline S.A. Spain Infanrix-Ipv+hib DE/H/0145/002 PL 10592/0216 Smithkline Beecham Ltd United Kingdom Infanrix-Ipv+hib (Dtpa- Ipv+hib) BE193961 Glaxosmithkline Biologicals S.A. Belgium Infanrix-Ipv+hib (Dtpa- Ipv+hib) 2005038707 Glaxosmithkline Biologicals S.A. Luxembourg Infanrix-Ipv-Hib OGYI-T-9521/01 Glaxosmithkline Kft. Hungary Infanrix-Ipv-Hib OGYI-T-9521/02 Glaxosmithkline Kft. Hungary Infanrix-Polio+hib DE/H/0145/002 13043 Glaxosmithkline Biologicals S.A. Finland Infanrix-Polio+hib 970540 Glaxosmithkline Ehf. Iceland Infanrix-Polio+hib 97-3108N Glaxosmithkline As Norway Infanrix-Polio+hib 13864 Glaxosmithkline Ab Sweden Infanrix polio+hib 19126 Glaxosmithkline Pharma A/S Denmark Infanrixquinta NL22370 Laboratoire Glaxosmithkline S.A.S. France Iνfανrιχ Ipv Hib 19619 Glaxosmithkline Biologicals S.A. Cyprus Iνfανrιχ Ipv Hib DE/H/0145/002 74423/22-10-2012 Glaxosmithkline Aebe Greece Pediacel UP/I-530-09/12-01/450 Sanofi Pasteur SA (France) Croatia Pediacel UP/I-530-09/07-01/203 Sanofi Pasteur SA (France) Croatia Pediacel 21485 Sanofi Pasteur Sa Cyprus Pediacel UK/H/2388/01/DC 59/128/11-C Sanofi Pasteur Sa Czech Republic Pediacel UK/H/2388/001 28104 Sanofi Pasteur Msd Finland Pediacel UK/H/2388/01 NL38860 Sanofi Pasteur MSD snc (France) France Pediacel UK/H/2388/01/DC MA573/01601 Sanofi Pasteur Sa Malta Pediacel UK/H/2388/001 RVG 106334 Sanofi Pasteur Msd Netherlands Pediacel UK/H/775/01 RVG 32118 Sanofi Pasteur Msd Netherlands Pediacel UK/H/2388/001 73.316 Sanofi Pasteur Msd S.A. (Spain) Spain Pediacel UK/H/2388/001 PL06745/0128 Sanofi Pasteur Msd Limited (Uk) United Kingdom Pediacel UK/H/775/01 PL 06745/0120 Sanofi Pasteur Msd Limited (Uk) United Kingdom Pentavac SE/H/0153/001 2-00227 Sanofi Pasteur Msd Snc Austria Pentavac SE/H/0153/001 BE196131 Sanofi Pasteur Msd Belgium Pentavac SE/H/0153/001 30187 Sanofi Pasteur Msd Denmark Pentavac SE/H/0153/001 13677 Sanofi Pasteur Msd Finland Pentavac SE/H/0153/001 NL22417 Sanofi Pasteur MSD S.N.C.France France Pentavac SE/H/0153/001 11A/97 Sanofi Pasteur Msd Gmbh Germany Pentavac SE/H/153/01/E01 65299/10/29-7-2011 Sanofi Pasteur Msd Snc Greece Pentavac SE/H/0153/001 970044 Sanofi Pasteur Msd Iceland Pentavac SE/H/0153/001 PA544/32/1 Sanofi Pasteur Msd Limited Ireland Pentavac SE/H/0153/001 034126019/M Sanofi Pasteur Msd Snc Italy EMA/483660/2015 Page 4/5

Pentavac SE/H/0153/001 034126021/M Sanofi Pasteur Msd Snc Italy Pentavac SE/H/0153/001 034126033/M Sanofi Pasteur Msd Snc Italy Pentavac SE/H/0153/001 034126045/M Sanofi Pasteur Msd Snc Italy Pentavac SE/H/0153/001 034126058/M Sanofi Pasteur Msd Snc Italy Pentavac SE/H/0153/001 034126060/M Sanofi Pasteur Msd Snc Italy Pentavac SE/H/0153/001 034126072/M Sanofi Pasteur Msd Snc Italy Pentavac SE/H/0153/001 034126084/M Sanofi Pasteur Msd Snc Italy Pentavac SE/H/0153/001 034126096/M Sanofi Pasteur Msd Snc Italy Pentavac SE/H/0153/001 034126108/M Sanofi Pasteur Msd Snc Italy Pentavac SE/H/0153/001 2009020171 Sanofi Pasteur Msd Luxembourg Pentavac SE/H/0153/001 97-710 Sanofi Pasteur Msd Norway Pentavac SE/H/0153/001 2782282 Sanofi Pasteur Msd, S.A. () Pentavac SE/H/0153/001 2782381 Sanofi Pasteur Msd, S.A. () Pentavac SE/H/0153/001 5458880 Sanofi Pasteur Msd, S.A. () Pentavac SE/H/0153/001 5458989 Sanofi Pasteur Msd, S.A. () Pentavac SE/H/0153/001 5459086 Sanofi Pasteur Msd, S.A. () Pentavac SE/H/0153/001 5459185 Sanofi Pasteur Msd, S.A. () Pentavac SE/H/0153/001 5459284 Sanofi Pasteur Msd, S.A. () Pentavac SE/H/0153/001 5459383 Sanofi Pasteur Msd, S.A. () Pentavac SE/H/0153/001 62.483 Sanofi Pasteur Msd S.A. (Spain) Spain Pentavac SE/H/0153/001 13523 Sanofi Pasteur Msd Sweden Pentavac SE/H/153/01/000 PL 06745/0101 Sanofi Pasteur Msd Limited (Uk) United Kingdom Pentaxim UP/I-530-09/10-02/383 Sanofi Pasteur Sa Croatia Pentaxim 19523 Sanofi Pasteur Sa Cyprus Pentaxim 430604 Sanofi Pasteur Sa Estonia Pentaxim NL 22 418 Sanofi Pasteur Sa France Pentaxim OGYI-T-9414/01-06-05 Sanofi Pasteur Sa Hungary Pentaxim 02-0311 Sanofi Pasteur Sa Latvia Pentaxim LT/1/99/3124/001-006 Sanofi Pasteur Sa Lithuania Pentaxim 10130 Sanofi Pasteur Sa Poland Pentaxim 4956/2012/01-05 Sanofi Pasteur Sa Romania Pentaxim 5363-I-629/11, 5363-I- 630/11,5363-I-631/11, 5363-I-632/11 Sanofi Pasteur Sa Slovenia инфанрикс-ipv+hib DE/H/0145/002 20090475 Glaxosmithkline Eood Bulgaria пентаксим II-9935/15.06.2010 Sanofi Pasteur Sa Bulgaria EMA/483660/2015 Page 5/5